Request that the FDA establish a regulatory framework for conducting expedited clinical trials of aging-related therapeutics within a 9-month time frame, modeled after FDA's COVID-19 emergency protocols | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-P-3216

Request that the FDA establish a regulatory framework for conducting expedited clinical trials of aging-related therapeutics within a 9-month time frame, modeled after FDA's COVID-19 emergency protocols

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensAug 18, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Response Letter from FDA CDER to Age Reversal Unity	Mar 2, 2026	--

Comment Statistics

Total Comments

Keywords

CDER and OC-OCE

Citizen Petition

Age Reversal Unity

Establish a regulatory framework

for conducting expedited clinical trials

of aging-related therapeutics within

a 9-month time frame

modeled after FDA's COVID-19

Data from Regulations.gov